Benchmark Genetics
supplies disease-free Atlantic salmon ova to the global industry every week of the year from its SalmoBreed program — 25 years old in 2026 — and reported in February 2026 that cross-generational genomic selection markedly raised resistance to cardiomyopathy syndrome (CMS),…
- Country
- Norway
Commercial
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aquaculture & fish farming | livestock-aqua | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.